Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology
Sign Up to like & getrecommendations! Published in 2022 at "Platelets"
DOI: 10.1080/09537104.2022.2042238
Abstract: Abstract Thromboembolic events are frequent and associated with poor outcome in severe COVID-19 disease. Anti-PF4/polyanion antibodies are related to heparin-induced thrombocytopenia (HIT) and thrombus formation, but data on these antibodies in unselected COVID-19 populations are… read more here.
Keywords: covid patients; polyanion antibodies; pathology; anti pf4 ... See more keywords
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14061133
Abstract: Rare cases of thrombocytopenia and thrombosis after anti-COVID-19 adenovirus-associated mRNA vaccines (VITT) due to platelet-activating anti-platelet-factor 4 (PF4)/polyanion antibodies have been reported. VITT laboratory diagnosis, similarly to heparin-induced thrombocytopenia (HIT) diagnosis, requires immunoassays for anti-PF4/polyanion… read more here.
Keywords: platelet activating; flow cytometry; polyanion antibodies; platelet ... See more keywords